Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
Add more filters










Publication year range
1.
J Physiol ; 600(10): 2429-2460, 2022 05.
Article in English | MEDLINE | ID: mdl-35389519

ABSTRACT

De novo missense variants in the KCNQ2 gene encoding the Kv7.2 subunit of voltage-gated potassium Kv7/M channels are the main cause of developmental and epileptic encephalopathy with neonatal onset. Although seizures usually resolve during development, cognitive/motor deficits persist. To gain a better understanding of the cellular mechanisms underlying network dysfunction and their progression over time, we investigated in vivo, using local field potential recordings of freely moving animals, and ex vivo in layers II/III and V of motor cortical slices, using patch-clamp recordings, the electrophysiological properties of pyramidal cells from a heterozygous knock-in mouse model carrying the Kv7.2 p.T274M pathogenic variant during neonatal, postweaning and juvenile developmental stages. We found that knock-in mice displayed spontaneous seizures preferentially at postweaning rather than at juvenile stages. At the cellular level, the variant led to a reduction in M ​​current density/conductance and to neuronal hyperexcitability. These alterations were observed during the neonatal period in pyramidal cells of layers II/III and during the postweaning stage in pyramidal cells of layer V. Moreover, there was an increase in the frequency of spontaneous network-driven events mediated by GABA receptors, suggesting that the excitability of interneurons was also increased. However, all these alterations were no longer observed in layers II/III and V of juvenile mice. Thus, our data indicate that the action of the variant is regulated developmentally. This raises the possibility that the age-related seizure remission observed in KCNQ2-related developmental and epileptic encephalopathy patients results from a time-limited alteration of Kv7 channel activity and neuronal excitability. KEY POINTS: The electrophysiological impact of the pathogenic c.821C>T mutation of the KCNQ2 gene (p.T274M variant in Kv7.2 subunit) related to developmental and epileptic encephalopathy has been analysed both in vivo and ex vivo in layers II/III and V of motor cortical slices from a knock-in mouse model during development at neonatal, postweaning and juvenile stages. M current density and conductance are decreased and the excitability of layer II/III pyramidal cells is increased in slices from neonatal and postweaning knock-in mice but not from juvenile knock-in mice. M current and excitability of layer V pyramidal cells are impacted in knock-in mice only at the postweaning stage. Spontaneous GABAergic network-driven events can be recorded until the postweaning stage, and their frequency is increased in layers II/III of the knock-in mice. Knock-in mice display spontaneous seizures preferentially at postweaning rather than at juvenile stages.


Subject(s)
Brain Diseases , KCNQ2 Potassium Channel , Seizures , Animals , Disease Models, Animal , Humans , KCNQ2 Potassium Channel/genetics , Mice , Nerve Tissue Proteins , Pyramidal Cells
2.
Front Cell Neurosci ; 14: 1, 2020.
Article in English | MEDLINE | ID: mdl-32038177

ABSTRACT

The epilepsy of infancy with migrating focal seizures (EIMFS; previously called Malignant migrating partial seizures of infancy) are early-onset epileptic encephalopathies (EOEE) that associate multifocal ictal discharges and profound psychomotor retardation. EIMFS have a genetic origin and are mostly caused by de novo mutations in the KCNT1 gene, and much more rarely in the KCNT2 gene. KCNT1 and KCNT2 respectively encode the KNa1.1 (Slack) and KNa1.2 (Slick) subunits of the sodium-dependent voltage-gated potassium channel KNa. Functional analyses of the corresponding mutant homomeric channels in vitro suggested gain-of-function effects. Here, we report two novel, de novo truncating mutations of KCNT2: one mutation is frameshift (p.L48Qfs43), is situated in the N-terminal domain, and was found in a patient with EOEE (possibly EIMFS); the other mutation is nonsense (p.K564*), is located in the C-terminal region, and was found in a typical EIMFS patient. Using whole-cell patch-clamp recordings, we have analyzed the functional consequences of those two novel KCNT2 mutations on reconstituted KNa1.2 homomeric and KNa1.1/KNa1.2 heteromeric channels in transfected chinese hamster ovary (CHO) cells. We report that both mutations significantly impacted on KNa function; notably, they decreased the global current density of heteromeric channels by ~25% (p.K564*) and ~55% (p.L48Qfs43). Overall our data emphasize the involvement of KCNT2 in EOEE and provide novel insights into the role of heteromeric KNa channel in the severe KCNT2-related epileptic phenotypes. This may have important implications regarding the elaboration of future treatment.

3.
Epilepsia ; 58(12): 2073-2084, 2017 12.
Article in English | MEDLINE | ID: mdl-29067685

ABSTRACT

OBJECTIVE: Kv7 channels mediate the voltage-gated M-type potassium current. Reduction of M current due to KCNQ2 mutations causes early onset epileptic encephalopathies (EOEEs). Mutations in STXBP1 encoding the syntaxin binding protein 1 can produce a phenotype similar to that of KCNQ2 mutations, suggesting a possible link between STXBP1 and Kv7 channels. These channels are known to be modulated by syntaxin-1A (Syn-1A) that binds to the C-terminal domain of the Kv7.2 subunit and strongly inhibits M current. Here, we investigated whether STXBP1could prevent this inhibitory effect of Syn-1A and analyzed the consequences of two mutations in STXBP1 associated with EOEEs. METHODS: Electrophysiologic analysis of M currents mediated by homomeric Kv7.2 or heteromeric Kv7.2/Kv7.3 channels in Chinese hamster ovary (CHO) cells coexpressing Syn-1A and/or STXBP1 or mutants STXBP1 p.W28* and p.P480L. Expression and interaction of these different proteins have been investigated using biochemical and co-immunoprecipitation experiments. RESULTS: Syn-1A decreased M currents mediated by Kv7.2 or Kv7.2/Kv7.3 channels. STXBP1 had no direct effects on M current but dampened the inhibition produced by Syn-1A by abrogating Syn-1A binding to Kv7 channels. The mutation p.W28*, but not p.P480L, failed to rescue M current from Syn-1A inhibition. Biochemical analysis showed that unlike the mutation p.W28*, the mutation p.P480L did not affect STXBP1 expression and reduced the interaction of Syn-1A with Kv7 channels. SIGNIFICANCE: These data indicate that there is a functional link between STXBP1 and Kv7 channels via Syn-1A, which may be important for regulating M-channel activity and neuronal excitability. They suggest also that a defect in Kv7 channel activity or regulation could be one of the consequences of some STXBP1 mutations associated with EOEEs. Furthermore, our data reveal that STXBP1 mutations associated with the Ohtahara syndrome do not necessarily result in protein haploinsufficiency.


Subject(s)
KCNQ2 Potassium Channel/genetics , Munc18 Proteins/genetics , Potassium Channel Blockers/pharmacology , Potassium Channels/drug effects , Spasms, Infantile/genetics , Syntaxin 1/pharmacology , Animals , Biotinylation , CHO Cells , Cricetinae , Cricetulus , Dose-Response Relationship, Drug , Electroencephalography , Humans , KCNQ1 Potassium Channel/antagonists & inhibitors , KCNQ1 Potassium Channel/genetics , KCNQ3 Potassium Channel/antagonists & inhibitors , KCNQ3 Potassium Channel/genetics
4.
Front Cell Neurosci ; 11: 149, 2017.
Article in English | MEDLINE | ID: mdl-28620281

ABSTRACT

The solute carrier family 25 (SLC25) drives the import of a large diversity of metabolites into mitochondria, a key cellular structure involved in many metabolic functions. Mutations of the mitochondrial glutamate carrier SLC25A22 (also named GC1) have been identified in early epileptic encephalopathy (EEE) and migrating partial seizures in infancy (MPSI) but the pathophysiological mechanism of GC1 deficiency is still unknown, hampered by the absence of an in vivo model. This carrier is mainly expressed in astrocytes and is the principal gate for glutamate entry into mitochondria. A sufficient supply of energy is essential for the proper function of the brain and mitochondria have a pivotal role in maintaining energy homeostasis. In this work, we wanted to study the consequences of GC1 absence in an in vitro model in order to understand if glutamate catabolism and/or mitochondrial function could be affected. First, short hairpin RNA (shRNA) designed to specifically silence GC1 were validated in rat C6 glioma cells. Silencing GC1 in C6 resulted in a reduction of the GC1 mRNA combined with a decrease of the mitochondrial glutamate carrier activity. Then, primary astrocyte cultures were prepared and transfected with shRNA-GC1 or mismatch-RNA (mmRNA) constructs using the Neon® Transfection System in order to target a high number of primary astrocytes, more than 64%. Silencing GC1 in primary astrocytes resulted in a reduced nicotinamide adenine dinucleotide (Phosphate) (NAD(P)H) formation upon glutamate stimulation. We also observed that the mitochondrial respiratory chain (MRC) was functional after glucose stimulation but not activated by glutamate, resulting in a lower level of cellular adenosine triphosphate (ATP) in silenced astrocytes compared to control cells. Moreover, GC1 inactivation resulted in an intracellular glutamate accumulation. Our results show that mitochondrial glutamate transport via GC1 is important in sustaining glutamate homeostasis in astrocytes. Main Points: The mitochondrial respiratory chain is functional in absence of GC1Lack of glutamate oxidation results in a lower global ATP levelLack of mitochondrial glutamate transport results in intracellular glutamate accumulation.

5.
Glia ; 65(2): 401-415, 2017 02.
Article in English | MEDLINE | ID: mdl-27862359

ABSTRACT

Glutamate transporters (EAATs) are important to maintain spatial and temporal specificity of synaptic transmission. Their efficiency to uptake and transport glutamate into the intracellular space depends on several parameters including the intracellular concentrations of Na+ and glutamate, the elevations of which may slow down the cycling rate of EAATs. In astrocytes, glutamate is maintained at low concentration due to the presence of specific enzymes such as glutamine synthase (GS). GS inhibition results in cytosolic accumulation of glutamate suggesting that the conversion of glutamate by GS is important for EAATs operation. Here we recorded astrocytes from juvenile rat neocortical slices and analyzed the consequences of elevated intracellular glutamate concentrations and of GS inhibition on the time course of synaptically evoked transporter current (STC). In slices from rats treated with methionine sulfoximine (MSO), a GS inhibitor, STC evoked by short burst of high frequency stimulation (HFS; 100 Hz for 100 ms) but not by low frequency stimulation (LFS; 0.1 Hz) was twice slower than STC evoked from saline injected rats. Same results were obtained for astrocytes recorded with pipette containing 3-10 mM glutamate and compared with cells recorded with 0 or1 mM glutamate in the patch pipette. We also showed that HFS elicited significantly larger NMDAR-excitatory postsynaptic currents (EPSCs) with a stronger peri/extrasynaptic component in pyramidal cells from MSO-treated compared with saline treated rats. Taken together our data demonstrate that the conversion of glutamate by GS is fundamental to ensure an efficient clearance of glutamate by EAATs and to prevent glutamate spillover. GLIA 2017;65:401-415.


Subject(s)
Astrocytes/metabolism , Glutamate-Ammonia Ligase/metabolism , Glutamic Acid/metabolism , Neocortex/cytology , Receptors, N-Methyl-D-Aspartate/metabolism , Amino Acids/metabolism , Animals , Animals, Newborn , Biophysics , Enzyme Inhibitors/pharmacology , Excitatory Amino Acid Agents/pharmacology , Excitatory Postsynaptic Potentials/drug effects , Female , GABA Agents/pharmacology , Humans , Male , Membrane Potentials , Methionine/analogs & derivatives , Methionine/pharmacology , Rats , Rats, Wistar , Time Factors
6.
Epilepsia ; 57(5): e87-93, 2016 05.
Article in English | MEDLINE | ID: mdl-27030113

ABSTRACT

Mutations in the KCNQ2 gene encoding the voltage-gated potassium channel subunit Kv7.2 cause early onset epileptic encephalopathy (EOEE). Most mutations have been shown to induce a loss of function or to affect the subcellular distribution of Kv7 channels in neurons. Herein, we investigated functional consequences and subcellular distribution of the p.V175L mutation of Kv7.2 (Kv7.2(V175L) ) found in a patient presenting EOEE. We observed that the mutation produced a 25-40 mV hyperpolarizing shift of the conductance-voltage relationship of both the homomeric Kv7.2(V175L) and heteromeric Kv7.2(V175L) /Kv7.3 channels compared to wild-type channels and a 10 mV hyperpolarizing shift of Kv7.2(V175L) /Kv7.2/Kv7.3 channels in a 1:1:2 ratio mimicking the patient situation. Mutant channels also displayed faster activation kinetics and an increased current density that was prevented by 1 µm linopirdine. The p.V175L mutation did not affect the protein expression of Kv7 channels and its localization at the axon initial segment. We conclude that p.V175L is a gain of function mutation. This confirms previous observations showing that mutations having opposite consequences on M channels can produce EOEE. These findings alert us that drugs aiming to increase Kv7 channel activity might have adverse effects in EOEE in the case of gain-of-function variants.


Subject(s)
KCNQ2 Potassium Channel/genetics , Polymorphism, Single Nucleotide/genetics , Spasms, Infantile/genetics , Animals , Ankyrins/metabolism , Anticonvulsants/pharmacology , CHO Cells , Carbamates/pharmacology , Cricetulus , Electric Stimulation , Female , Hippocampus/cytology , Humans , Indoles/pharmacology , Male , Membrane Potentials/genetics , Membrane Potentials/physiology , Neurons/drug effects , Neurons/physiology , Patch-Clamp Techniques , Phenylenediamines/pharmacology , Potassium Channel Blockers/pharmacology , Pyridines/pharmacology
7.
Neurobiol Dis ; 80: 80-92, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26007637

ABSTRACT

Mutations in the KCNQ2 gene encoding the voltage-dependent potassium M channel Kv7.2 subunit cause either benign epilepsy or early onset epileptic encephalopathy (EOEE). It has been proposed that the disease severity rests on the inhibitory impact of mutations on M current density. Here, we have analyzed the phenotype of 7 patients carrying the p.A294V mutation located on the S6 segment of the Kv7.2 pore domain (Kv7.2(A294V)). We investigated the functional and subcellular consequences of this mutation and compared it to another mutation (Kv7.2(A294G)) associated with a benign epilepsy and affecting the same residue. We report that all the patients carrying the p.A294V mutation presented the clinical and EEG characteristics of EOEE. In CHO cells, the total expression of Kv7.2(A294V) alone, assessed by western blotting, was only 20% compared to wild-type. No measurable current was recorded in CHO cells expressing Kv7.2(A294V) channel alone. Although the total Kv7.2(A294V) expression was rescued to wild-type levels in cells co-expressing the Kv7.3 subunit, the global current density was still reduced by 83% compared to wild-type heteromeric channel. In a configuration mimicking the patients' heterozygous genotype i.e., Kv7.2(A294V)/Kv7.2/Kv7.3, the global current density was reduced by 30%. In contrast to Kv7.2(A294V), the current density of homomeric Kv7.2(A294G) was not significantly changed compared to wild-type Kv7.2. However, the current density of Kv7.2(A294G)/Kv7.2/Kv7.3 and Kv7.2(A294G)/Kv7.3 channels were reduced by 30% and 50% respectively, compared to wild-type Kv7.2/Kv7.3. In neurons, the p.A294V mutation induced a mislocalization of heteromeric mutant channels to the somato-dendritic compartment, while the p.A294G mutation did not affect the localization of the heteromeric channels to the axon initial segment. We conclude that this position is a hotspot of mutation that can give rise to a severe or a benign epilepsy. The p.A294V mutation does not exert a dominant-negative effect on wild-type subunits but alters the preferential axonal targeting of heteromeric Kv7 channels. Our data suggest that the disease severity is not necessarily a consequence of a strong inhibition of M current and that additional mechanisms such as abnormal subcellular distribution of Kv7 channels could be determinant.


Subject(s)
Brain/physiopathology , Epilepsy/genetics , KCNQ2 Potassium Channel/genetics , KCNQ2 Potassium Channel/physiology , Animals , Brain/metabolism , CHO Cells , Cells, Cultured , Cricetulus , Epilepsy/diagnosis , Epilepsy/physiopathology , Hippocampus/metabolism , Humans , KCNQ2 Potassium Channel/metabolism , Mutation , Neurons/metabolism , Phenotype
8.
Cereb Cortex ; 23(6): 1484-94, 2013 Jun.
Article in English | MEDLINE | ID: mdl-22628459

ABSTRACT

Epileptic encephalopathies comprise a heterogeneous group of severe infantile disorders for which the pathophysiological basis of epilepsy is inaccurately clarified by genotype-phenotype analysis. Because a deficit of GABA neurons has been found in some of these syndromes, notably in patients with X-linked lissencephaly with abnormal genitalia, epilepsy was suggested to result from an imbalance in GABAergic inhibition, and the notion of "interneuronopathy" was proposed. Here, we studied the impact of a polyalanine expansion of aristaless-related homeobox (ARX) gene, a mutation notably found in West and Ohtahara syndromes. Analysis of Arx((GCG)7/Y) knock-in mice revealed that GABA neuron development is not affected. Moreover, pyramidal cell migration and cortical layering are unaltered in these mice. Interestingly, electrophysiological recordings show that hippocampal pyramidal neurons displayed a frequency of inhibitory postsynaptic currents similar to wild-type (WT) mice. However, these neurons show a dramatic increase in the frequency of excitatory inputs associated with a remodeling of their axonal arborization, suggesting that epilepsy in Arx((GCG)7/Y)mice would result from a glutamate network remodeling. We therefore propose that secondary alterations are instrumental for the development of disease-specific phenotypes and should be considered to explain the phenotypic diversity associated with epileptogenic mutations.


Subject(s)
GABAergic Neurons/physiology , Gene Expression Regulation, Developmental/genetics , Glutamates/metabolism , Homeodomain Proteins/genetics , Peptides/genetics , Transcription Factors/genetics , gamma-Aminobutyric Acid/metabolism , 6-Cyano-7-nitroquinoxaline-2,3-dione/pharmacology , Action Potentials/drug effects , Action Potentials/genetics , Age Factors , Animals , Animals, Newborn , Cell Movement/genetics , Doublecortin Protein , Electroporation , Embryo, Mammalian , Excitatory Amino Acid Antagonists/pharmacology , Female , GABAergic Neurons/cytology , Glutamate Decarboxylase/metabolism , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , HEK293 Cells , Humans , Lysine/analogs & derivatives , Lysine/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Nerve Tissue Proteins/metabolism , Organ Culture Techniques , Patch-Clamp Techniques , RNA, Small Interfering/genetics , Statistics, Nonparametric , Synaptic Potentials/drug effects , Synaptic Potentials/genetics , Transfection
9.
J Neurosci ; 32(19): 6688-98, 2012 May 09.
Article in English | MEDLINE | ID: mdl-22573691

ABSTRACT

During early postnatal development, neuronal networks successively produce various forms of spontaneous patterned activity that provide key signals for circuit maturation. Initially, in both rodent hippocampus and neocortex, coordinated activity emerges in the form of synchronous plateau assemblies (SPAs) that are initiated by sparse groups of gap-junction-coupled oscillating neurons. Subsequently, SPAs are replaced by synapse-driven giant depolarizing potentials (GDPs). Whether these sequential changes in mechanistically distinct network activities correlate with modifications in single-cell properties is unknown. To determine this, we studied the morphophysiological fate of single SPA cells as a function of development. We focused on CA3 GABAergic interneurons, which are centrally involved in generating GDPs in the hippocampus. As the network matures, GABAergic neurons are engaged more in GDPs and less in SPAs. Using inducible genetic fate mapping, we show that the individual involvement of GABAergic neurons in SPAs is correlated to their temporal origin. In addition, we demonstrate that the SPA-to-GDP transition is paralleled by a remarkable maturation in the morphophysiological properties of GABAergic neurons. Compared with those involved in GDPs, interneurons participating in SPAs possess immature intrinsic properties, receive synaptic inputs spanning a wide amplitude range, and display large somata as well as membrane protrusions. Thus, a developmental switch in the morphophysiological properties of GABAergic interneurons as they progress from SPAs to GDPs marks the emergence of synapse-driven network oscillations.


Subject(s)
Hippocampus/growth & development , Interneurons/cytology , Interneurons/physiology , Nerve Net/growth & development , Animals , Animals, Newborn , Female , Gene Knock-In Techniques , Hippocampus/cytology , Male , Mice , Mice, Transgenic , Nerve Net/cytology , Organ Culture Techniques
10.
J Physiol ; 589(Pt 10): 2475-96, 2011 May 15.
Article in English | MEDLINE | ID: mdl-21486764

ABSTRACT

KCC2 is a neuron-specific potassium-chloride co-transporter controlling intracellular chloride homeostasis in mature and developing neurons. It is implicated in the regulation of neuronal migration, dendrites outgrowth and formation of the excitatory and inhibitory synaptic connections. The function of KCC2 is suppressed under several pathological conditions including neuronal trauma, different types of epilepsies, axotomy of motoneurons, neuronal inflammations and ischaemic insults. However, it remains unclear how down-regulation of the KCC2 contributes to neuronal survival during and after toxic stress. Here we show that in primary hippocampal neuronal cultures the suppression of the KCC2 function using two different shRNAs, dominant-negative KCC2 mutant C568A or DIOA inhibitor, increased the intracellular chloride concentration [Cl⁻]i and enhanced the toxicity induced by lipofectamine-dependent oxidative stress or activation of the NMDA receptors. The rescuing of the KCC2 activity using over-expression of the active form of the KCC2, but not its non-active mutant Y1087D, effectively restored [Cl⁻]i and enhanced neuronal resistance to excitotoxicity. The reparative effects of KCC2 were mimicked by over-expression of the KCC3, a homologue transporter. These data suggest an important role of KCC2-dependent potassium/chloride homeostasis under neurototoxic conditions and reveal a novel role of endogenous KCC2 as a neuroprotective molecule.


Subject(s)
Chlorides/metabolism , Hippocampus/metabolism , Symporters/metabolism , Animals , Cell Survival/drug effects , Cells, Cultured , Down-Regulation , Lipids/adverse effects , Neurons/drug effects , Neurons/metabolism , Oxidative Stress/drug effects , Patch-Clamp Techniques , Rats , Rats, Wistar , Receptors, N-Methyl-D-Aspartate/agonists , Symporters/genetics , gamma-Aminobutyric Acid/metabolism , K Cl- Cotransporters
11.
Cereb Cortex ; 20(11): 2694-701, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20164125

ABSTRACT

Previous reports indicate that in utero knockdown of doublecortin (DCX) results in the genesis of a subcortical heterotopia reminiscent of the doublecortex observed in female patients with DCX mutations. It has also been shown that these rats display an increased susceptibility to convulsant agents and increased cortical neurons excitability; but it is presently unknown whether they display spontaneous seizures. Furthermore, the link between the size of heterotopia and the clinical manifestation remained to be elucidated. Using video-electrocorticogram recordings, we now report that DCX knockdown induces frequent spontaneous seizures commonly associated with myoclonic jerks in adult rats. Surprisingly, epilepsy occurred even in rats with very small subcortical heterotopias, as revealed by histological analysis of recorded animals. Moreover, the severity of the epileptic manifestations was positively correlated with both the size of the subcortical heterotopia and the age of recorded animals; thus, epileptic features were not detected in immature affected rats. In conclusion, our data demonstrate for the first time that subtle alterations can yield epilepsy and reveal a strong correlation between thicknesses of subcortical heterotopia, age of affected individuals and clinical impairment.


Subject(s)
Disease Models, Animal , Epilepsy/genetics , Epilepsy/physiopathology , Malformations of Cortical Development/genetics , Malformations of Cortical Development/physiopathology , Microtubule-Associated Proteins/genetics , Neuropeptides/genetics , Animals , Animals, Newborn , Doublecortin Domain Proteins , Doublecortin Protein , Epilepsy/diagnosis , Female , Gene Knockdown Techniques/methods , Humans , Male , Malformations of Cortical Development/diagnosis , Microtubule-Associated Proteins/biosynthesis , Microtubule-Associated Proteins/deficiency , Neuropeptides/biosynthesis , Neuropeptides/deficiency , Rats , Rats, Wistar
12.
Ann Neurol ; 66(2): 209-18, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19743469

ABSTRACT

OBJECTIVE: The mechanisms of epileptogenesis in Sturge-Weber syndrome (SWS) are unknown. We explored the properties of neurons from human pediatric SWS cortex in vitro and tested in particular whether gamma-aminobutyric acid (GABA) excites neurons in SWS cortex, as has been suggested for various types of epilepsies. METHODS: Patch-clamp and field potential recordings and dynamic biphoton imaging were used to analyze cortical tissue samples obtained from four 6- to 14-month-old pediatric SWS patients during surgery. RESULTS: Neurons in SWS cortex were characterized by a relatively depolarized resting membrane potential, as was estimated from cell-attached recordings of N-methyl-D-aspartate channels. Many cells spontaneously fired action potentials at a rate proportional to the level of neuronal depolarization. The reversal potential for GABA-activated currents, assessed by cell-attached single channel recordings, was close to the resting membrane potential. All spontaneously firing neurons recorded in cell-attached mode or imaged with biphoton microscopy were inhibited by GABA. Spontaneous epileptiform activity in the form of recurrent population bursts was suppressed by glutamate receptor antagonists, the GABA(A) receptor agonist isoguvacine, and the positive allosteric GABA(A) modulator diazepam. Blockade of GABA(A) receptors aggravated spontaneous epileptiform activity. The NKCC1 antagonist bumetanide had little effect on epileptiform activity. INTERPRETATION: SWS cortical neurons have a relatively depolarized resting membrane potential and spontaneously fire action potentials that may contribute to increased network excitability. In contrast to previous data depicting excitatory and proconvulsive actions of GABA in certain pediatric and adult epilepsies, GABA plays mainly an inhibitory and anticonvulsive role in SWS pediatric cortex.


Subject(s)
Cerebral Cortex/physiopathology , Neural Inhibition/physiology , Neurons/physiology , Sturge-Weber Syndrome/physiopathology , gamma-Aminobutyric Acid/metabolism , Action Potentials/drug effects , Action Potentials/physiology , Bumetanide/pharmacology , Cerebral Cortex/drug effects , Diazepam/pharmacology , Epilepsy/drug therapy , Epilepsy/physiopathology , Excitatory Amino Acid Antagonists/pharmacology , GABA Agonists/pharmacology , GABA Modulators/pharmacology , GABA-A Receptor Agonists , Humans , In Vitro Techniques , Infant , Isonicotinic Acids/pharmacology , Membrane Potentials/drug effects , Membrane Potentials/physiology , Neural Inhibition/drug effects , Neurons/drug effects , Receptors, GABA-A/metabolism , Receptors, Glutamate/metabolism , Sodium Potassium Chloride Symporter Inhibitors/pharmacology , Solute Carrier Family 12, Member 2
13.
J Neurosci ; 29(2): 313-27, 2009 Jan 14.
Article in English | MEDLINE | ID: mdl-19144832

ABSTRACT

In human patients, cortical dysplasia produced by Doublecortin (DCX) mutations lead to mental retardation and intractable infantile epilepsies, but the underlying mechanisms are not known. DCX(-/-) mice have been generated to investigate this issue. However, they display no neocortical abnormality, lessening their impact on the field. In contrast, in utero knockdown of DCX RNA produces a morphologically relevant cortical band heterotopia in rodents. On this preparation we have now compared the neuronal and network properties of ectopic, overlying, and control neurons in an effort to identify how ectopic neurons generate adverse patterns that will impact cortical activity. We combined dynamic calcium imaging and anatomical and electrophysiological techniques and report now that DCX(-/-)EGFP(+)-labeled ectopic neurons that fail to migrate develop extensive axonal subcortical projections and retain immature properties, and most of them display a delayed maturation of GABA-mediated signaling. Cortical neurons overlying the heterotopia, in contrast, exhibit a massive increase of ongoing glutamatergic synaptic currents reflecting a strong reactive plasticity. Neurons in both experimental fields are more frequently coactive in coherent synchronized oscillations than control cortical neurons. In addition, both fields displayed network-driven oscillations during evoked epileptiform burst. These results show that migration disorders produce major alterations not only in neurons that fail to migrate but also in their programmed target areas. We suggest that this duality play a major role in cortical dysfunction of DCX brains.


Subject(s)
Cerebral Cortex/abnormalities , Disease Models, Animal , Malformations of Cortical Development/genetics , Malformations of Cortical Development/pathology , Nerve Net/physiopathology , Analysis of Variance , Animals , Animals, Genetically Modified , Animals, Newborn , Bicuculline/pharmacology , Cerebral Cortex/drug effects , Cerebral Cortex/embryology , Cerebral Cortex/pathology , Doublecortin Domain Proteins , Doublecortin Protein , Electroporation/methods , Excitatory Amino Acid Antagonists/pharmacology , Female , GABA Antagonists/pharmacology , Glutamate Decarboxylase/metabolism , Glutamic Acid/pharmacology , Green Fluorescent Proteins/genetics , Humans , In Vitro Techniques , Membrane Potentials/drug effects , Membrane Potentials/genetics , Microtubule-Associated Proteins/genetics , Mutation/genetics , Nerve Net/drug effects , Neurons/drug effects , Neurons/pathology , Neuropeptides/genetics , Pregnancy , Quinoxalines/pharmacology , RNA, Small Interfering/pharmacology , Rats , Rats, Wistar , Sodium Channel Blockers/pharmacology , Tetrodotoxin/pharmacology , Valine/analogs & derivatives , Valine/pharmacology , gamma-Aminobutyric Acid/pharmacology
14.
Epilepsia ; 48(1): 169-74, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17241224

ABSTRACT

PURPOSE: To determine the electrophysiological pattern and propose a clinical relevance of a deficient glutamate transport in the developing brain. METHODS: (a) Surface EEG-video monitoring in freely moving pups; (b) intracortical multiple unit activity (MUA) and local field potential recordings in 5- to 7-day-old rats after pharmacological inhibition of the glutamate transporters by DL-TBOA. RESULTS: Glutamate transporters inhibition alters the background cortical electrical activity inducing a dominant and persistent pattern of bilateral recurrent paroxysmal bursts alternating with periods of hypoactivity and also partial seizures. Intracortical local field recordings show that paroxysmal bursts are associated with multiunits and gamma oscillations separated by periods of silence. This cortical activity involves the activation of ionotropic glutamate receptors and was not observed after kainate and pilocarpine administration. CONCLUSIONS: We show that a dysfunction of glutamate transporters in immature rats leads to a singular cortical activity that is reminiscent of a "suppression-burst" pattern. We propose that an early deficiency of glutamate transport may underlie some early onset epilepsies.


Subject(s)
Amino Acid Transport System X-AG/antagonists & inhibitors , Electroencephalography/statistics & numerical data , Epilepsies, Partial/physiopathology , Amino Acid Transport System X-AG/drug effects , Amino Acid Transport System X-AG/physiology , Animals , Animals, Newborn , Aspartic Acid/administration & dosage , Aspartic Acid/pharmacology , Cerebral Cortex/drug effects , Cerebral Cortex/growth & development , Cerebral Cortex/physiopathology , Disease Models, Animal , Epilepsies, Partial/metabolism , Functional Laterality/drug effects , Functional Laterality/physiology , Injections, Intraventricular , Kainic Acid/pharmacology , Male , Pilocarpine/pharmacology , Rats , Rats, Wistar , Receptors, Glutamate/drug effects , Receptors, Glutamate/metabolism , Receptors, Glutamate/physiology , Videotape Recording
15.
J Neurosci ; 24(13): 3289-94, 2004 Mar 31.
Article in English | MEDLINE | ID: mdl-15056708

ABSTRACT

Glutamate transporters are operative at an early developmental stage well before synapse formation, but their functional significance has not been determined. We now report that blockade of glutamate transporters in the immature neocortex generates recurrent NMDA receptor-mediated currents associated with synchronous oscillations of [Ca2+]i in the entire neuronal population. Intracerebroventricular injections of the blocker to pups generate seizures that are prevented by coinjections of NMDA receptor blockers. Therefore, the early expression of glutamate transporters plays a central role to prevent the activation by local glutamate concentrations of NMDA receptors and the generation of seizures that may alter the construction of cortical networks. A dysfunction of glutamate transporters may be a central event in early infancy epilepsy syndromes.


Subject(s)
Amino Acid Transport System X-AG/physiology , Neocortex/growth & development , Neocortex/physiopathology , Seizures/prevention & control , Seizures/physiopathology , Amino Acid Transport System X-AG/antagonists & inhibitors , Animals , Animals, Newborn , Aspartic Acid/pharmacology , Biological Clocks/drug effects , Biological Clocks/physiology , Calcium Signaling/drug effects , Calcium Signaling/physiology , Excitatory Amino Acid Agonists/pharmacology , Glutamic Acid/metabolism , N-Methylaspartate/pharmacology , Neocortex/drug effects , Neurons/metabolism , Patch-Clamp Techniques , Rats , Rats, Wistar , Receptors, N-Methyl-D-Aspartate/metabolism
16.
Neuron ; 36(6): 1051-61, 2002 Dec 19.
Article in English | MEDLINE | ID: mdl-12495621

ABSTRACT

GABA and glutamate receptors are expressed in immature "silent" CA1 pyramidal neurons prior to synapse formation, but their function is unknown. We now report the presence of tonic, spontaneous, and evoked currents in embryonic and neonatal CA1 neurons mediated primarily by the activation of GABA(A) receptors. These currents are mediated by a nonconventional release of transmitters, as they persist in the presence of calcium channel blockers or botulinium toxin and are observed in Munc18-1-deficient mice in which vesicular release is abolished. This paracrine communication is modulated by glutamate but not GABA transporters, which do not operate during this period of life. Thus, a Ca(2+)- and SNARE-independent release of transmitters underlies a paracrine mode of communication before synapse formation.


Subject(s)
Cell Differentiation/physiology , Glutamic Acid/metabolism , Hippocampus/embryology , Paracrine Communication/physiology , Pyramidal Cells/metabolism , Synapses/metabolism , Vesicular Transport Proteins , gamma-Aminobutyric Acid/metabolism , Animals , Calcium/metabolism , Calcium Signaling/physiology , Electric Stimulation , Excitatory Amino Acid Antagonists/pharmacology , Fetus , GABA Antagonists/pharmacology , GABA-A Receptor Antagonists , Hippocampus/cytology , Hippocampus/metabolism , Membrane Potentials/drug effects , Membrane Potentials/physiology , Membrane Proteins/metabolism , Mice , Mice, Knockout , Pyramidal Cells/cytology , Rats , Rats, Wistar , Receptors, GABA-A/metabolism , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Receptors, N-Methyl-D-Aspartate/metabolism , SNARE Proteins , Synapses/ultrastructure , Synaptic Transmission/drug effects , Synaptic Transmission/physiology
17.
Neuron ; 35(1): 147-59, 2002 Jul 03.
Article in English | MEDLINE | ID: mdl-12123615

ABSTRACT

The relative contribution of kainate receptors to ongoing glutamatergic activity is at present unknown. We report the presence of spontaneous, miniature, and minimal stimulation-evoked excitatory postsynaptic currents (EPSCs) that are mediated solely by kainate receptors (EPSC(kainate)) or by both AMPA and kainate receptors (EPSC(AMPA/kainate)). EPSC(kainate) and EPSC(AMPA/kainate) are selectively enriched in CA1 interneurons and mossy fibers synapses of CA3 pyramidal neurons, respectively. In CA1 interneurons, the decay time constant of EPSC(kainate) (circa 10 ms) is comparable to values obtained in heterologous expression systems. In both hippocampal neurons, the quantal release of glutamate generates kainate receptor-mediated EPSCs that provide as much as half of the total glutamatergic current. Kainate receptors are, therefore, key players of the ongoing glutamatergic transmission in the hippocampus.


Subject(s)
Excitatory Postsynaptic Potentials/physiology , Glutamic Acid/metabolism , Hippocampus/metabolism , Presynaptic Terminals/metabolism , Receptors, AMPA/metabolism , Receptors, Kainic Acid/metabolism , Synaptic Vesicles/metabolism , Animals , Dynorphins/metabolism , Electric Stimulation , Excitatory Amino Acid Antagonists/pharmacology , Excitatory Postsynaptic Potentials/drug effects , GABA Antagonists/pharmacology , Hippocampus/cytology , Hippocampus/drug effects , Interneurons/cytology , Interneurons/drug effects , Interneurons/metabolism , Kinetics , Male , Mossy Fibers, Hippocampal/drug effects , Mossy Fibers, Hippocampal/metabolism , Mossy Fibers, Hippocampal/ultrastructure , Organ Culture Techniques , Presynaptic Terminals/drug effects , Pyramidal Cells/cytology , Pyramidal Cells/drug effects , Pyramidal Cells/metabolism , Rats , Rats, Wistar , Receptors, AMPA/antagonists & inhibitors , Receptors, Kainic Acid/antagonists & inhibitors , Sodium Channel Blockers/pharmacology , Synaptic Transmission/drug effects , Synaptic Transmission/physiology , Synaptic Vesicles/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...